Market Entry into Europe for Pharma & Biotech
Expand your pharmaceutical business into Europe with a partner who understands both strategy and execution
Europe is the world's second largest pharmaceutical market, representing 500+ million patients across more than 30 interconnected countries. It offers scale, pricing potential, and long-term stability.
But entry requires navigating a complex EU regulatory framework, national differences in legislation, strict EU-GMP requirements and QP oversight, multiple registration procedures, and operational obligations long before commercialization.
Without European infrastructure, expansion can quickly become fragmented and resource-heavy.
One Integrated Pathway to European Market Access
At QbD Group, we align regulatory strategy with operational readiness. This reduces risk, shortens timelines, and ensures sustainable entry into the European pharmaceutical market.
We support you from early planning to commercialization and beyond, with one coordinated structure and a single point of accountability.
Key challenges we address
A complex EU regulatory framework
Navigating different regulatory pathways across EU member states requires deep expertise and careful planning.
National differences in legislation
Each EU country has specific national requirements that must be addressed alongside centralized regulations.
Strict EU-GMP requirements and QP oversight
Manufacturing and importation must comply with EU-GMP standards under Qualified Person supervision.
Multiple registration procedures
Centralized, decentralized, and mutual recognition procedures each demand different documentation strategies.
Operational obligations long before commercialization
Supply chain, pharmacovigilance, and quality systems must be established well before product launch.
How We Support Your European Expansion
We support pharmaceutical companies across every stage of their European expansion. From early strategic planning and EU-GMP readiness to registration, launch preparation, and ongoing lifecycle management, our services are structured to guide you step by step through a compliant and controlled market entry.
Strategic Preparation
Pre-Registration & EU-GMP Readiness
Build a strong foundation before entering the European market. We deliver EU market analysis, regulatory road mapping, clinical and product development support, and EU-GMP audits for APIs and finished products — alongside the MAH, Pharmacovigilance, and EU QP structures needed for compliance from day one.
Start your European journey with a strong and fully compliant strategic foundation.
Regulatory Approval
Registration & Submission Management
Navigate the European approval process with clarity and control. We define the right registration strategy, prepare your Marketing Authorization dossier in eCTD format, and manage submissions through to approval — ensuring full alignment with EU regulatory requirements at every step.
Reach the European market with a streamlined, expertly managed approval pathway.
Operational Setup
Launch & EU-GMP Importation
Get all critical operations in place before commercialization begins. We establish your EU supply chain, coordinate serialization, and provide GMP-compliant import warehousing and QC testing. Our EU Qualified Persons handle batch certification and release in line with EU-GMP standards.
Launch confidently with integrated, compliant operations fully aligned with EU requirements.
Lifecycle Management
Marketing Authorization & Safety Oversight
Sustain your market access with structured regulatory and safety support. We manage renewals, variations, and full Pharmacovigilance and Medical Information services — keeping your product compliant, safe, and commercially stable across Europe.
Safeguard your authorization and sustain your market presence with expert lifecycle and safety management.
Why Choose QbD for European Market Entry
Decades of experience navigating Europe's complex regulatory landscape for pharma and biotech companies worldwide.
Each story is different
At QbD we understand each story is different so we can support you with tailor made solutions.
We provide expert support to all types of companies involved in the importation, manufacturing, distribution, and development of pharmaceuticals for the European market.
Whether you want to bring medicines into Europe, manufacture under EU GMP regulations or ensuring compliance across the supply chain we have the expertise to guide you through every step.
Do you need help with your European market launch? Any type of product and any type of need, we got you covered!
Why QbD Group?
European expansion requires more than isolated expertise. It requires integration.
We align regulatory strategy with operational readiness, reducing risk, shortening timelines, and ensuring sustainable entry into the European pharmaceutical market:
- Integrated End-to-End Capabilities: Regulatory, quality, QP, PV, and supply chain services coordinated within one structure. Scalable support from submission to commercialization, backed by EU-based warehousing and import capabilities.
- Certified EU-GMP Infrastructure: GMP-licensed facilities enabling compliant importation, batch certification, and quality oversight under recognized EU standards.
- 700+ Multidisciplinary Experts: Specialists across regulatory affairs, quality, QC, QP, and PV supporting every stage of your product lifecycle.
- Single Point of Accountability: A dedicated project manager coordinating all workstreams and ensuring structured, consistent progress.
- Proven Global Track Record: 4,500+ projects delivered and 1,200+ clients supported across diverse markets and product types.
Client cases
Proven results across Europe
Our clients' success is the best measure of what we do. Across therapeutic areas, geographies, and product types, QbD Group has helped pharmaceutical companies navigate the complexity of European market entry — from first submission to sustained commercialization.
Market AccessSupporting Market Access to Essential Medicines in Europe
Helping a global pharmaceutical company navigate EU regulatory requirements for essential medicine market entry
- Challenge: A global pharmaceutical company needed to bring essential medicines to the European market, facing complex regulatory pathways across multiple EU member states.
- Approach: QbD provided end-to-end regulatory support including MA dossier preparation, submission management, and coordination with national authorities across targeted European markets.
- Result: Successful market authorization and commercial launch across multiple European countries, ensuring patient access to essential medicines while maintaining full regulatory compliance.
FAQ
Frequently asked questions
Need help with your European market launch?
Any type of product and any type of need — we've got you covered.